SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-035670
Filing Date
2022-12-16
Accepted
2022-12-16 08:00:30
Documents
14
Period of Report
2022-12-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 64439
2 ex10-1.htm EX-10.1 176637
  Complete submission text file 0001493152-22-035670.txt   511071

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bfri-20221212.xsd EX-101.SCH 4288
4 XBRL DEFINITION FILE bfri-20221212_def.xml EX-101.DEF 27600
5 XBRL LABEL FILE bfri-20221212_lab.xml EX-101.LAB 38253
6 XBRL PRESENTATION FILE bfri-20221212_pre.xml EX-101.PRE 26217
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6828
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 221466481
SIC: 2834 Pharmaceutical Preparations